Horizons Clinical Research Center, LLC Report issue

For profit Phase 3
Founded: Denver CO United States (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2010
NCT01188928
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophic Vaginitis (Phase 3)

Atrophy (Phase 3)

Psoriasis (Phase 3)

Vaginitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4